Done

Hi Change !


did you get it

MEAD
I had no idea you were a GOD-
perfect in everyway , never a misspelling or grammatical errors, thanks for pointing out my flaws, you must be so fun to be around

mead good job on deflecting on everything I posted ,focusing on spelling is much more important to you.
I am a cyrcadia holder and I am trying in a way to protect llbo holders.
I remember reading some of your post where you were saying cisco would buy llbo for $10+ tells me all I need to know about you .

next time cyrcadia gives a update I will share it , first i have find a way to make sure your eyes don't see it

Nevermind..

Guys come to BMXC

hey Voo , hope you make lots of money $$$$$
hope your time comes soon!

im just not excited as i was before , mostly because i moved too crypto,.
i just want to say i hope all longs make lots of money.
i have nothing against anyone on the board , just very disappointed with how long everything took vs what i was told ..or at least what i thought..


at the very least LLbo should get a decent run but i would be a seller at that point ,, look at the charts, they never once held after a spike.
and then re-enter if wanted to
but that's just my opinion

Hey what are your feeling on llbo

Breath, urine tests detect breast cancer more accurately, say researchers

since you so focused on the word "can" in the old headline I found a different one that says it detects breast cancer more accurately
maybe you can now focus on results vs the lies you posted

this is in fact proven and available

Using readily-available technology, Israeli scientists have demonstrated unprecedented success in identifying early tumors.

The new technology, using commercially available technology, has just been published in the journal Computers in Biology and Medicine.

In their study, researchers detected breast cancer with more than 95% average accuracy using two different commercial electronic noses (e-noses) that identify unique breath patterns in women with breast cancer. In addition, their revamped statistical analyses of urine samples submitted both by healthy patients and those diagnosed with breast cancer yielded 85% average accuracy.
https://www.jpost.com/HEALTH-SCIENCE/Breath-urine-tests-detect-breast-cancer-more-accurately-say-researchers-552743

amazing is your getting excited and feel the need to defend llbo after my posting , are you aware that you would still need some sort of scan even if the urine test work 100%, get a grip
showing up to ihub multiple times a day for years and expecting to see something different is starting to get you and almost everyone else,
its tortuous


I'm free to post whatever i want, also stop with lies , I'm not trying to buy llbo . there was 20$ of trading on Friday with a 20% spread , that doesn't sound ideal for what your saying I'm doing, does it ?


xd456xd - thanks for asking me a question vs attacking with lies

don't think the itbra will be successful even if they get to market , which i believe to be a longshot at best, dont think women will adapt to it , so it will fail , that's on top of all the bs with delays and deals last few years.
every year we saw this is the year or it wont work out ,, well i think those years already past , its a wrap imo - goodluck , i already made few 100k in my cryptos so i dont need this to hit for me , jim need to be held accountable though imo - goodluck

you realize what you're showing me is not at all related to the trial of 120,000 that has funding by Amazon, Bezos Expeditions, Bill Gates, Bristol-Myers Squibb, Celgene, GV, Illumina, Johnson & Johnson Innovation, Merck, McKesson Ventures, Sutter Hill Ventures, Tencent, Varian Medical Systems, and other financial partners. that raised close to a billion dollars. https://grail.com/news/

there are no results posted anywhere - https://clinicaltrials.gov/ct2/show/results/NCT03085888

In order to enable the most accurate detection of early-stage cancer, GRAIL is conducting one of the largest clinical study programs ever pursued in genomic medicine. We are collaborating with leading community and academic medical centers to conduct studies enrolling tens of thousands of people to identify the patterns required to detect many types of cancer, and studies enrolling hundreds of thousands of people to evaluate the potential clinical validity and utility of GRAIL’s products.


this is pretty cut and dry,
the players that are involved , the money that is raised , amount of people in the trials , the amount of people evaluating the products.
also no results being posted for this trial

this post to get anyone to sell
this is post on whats on the horizon


About GRAIL
GRAIL is a life sciences company whose mission is to detect cancer early when it can be cured. GRAIL is using the power of high-intensity sequencing, population-scale clinical trials, and state of the art Computer Science and Data Science to enhance the scientific understanding of cancer biology and develop blood tests for early-stage cancer detection. The company has secured over $1B in venture funding led by ARCH Venture Partners and including Amazon, Bezos Expeditions, Bill Gates, Bristol-Myers Squibb, Celgene, GV, Illumina, Johnson & Johnson Innovation, Merck, McKesson Ventures, Sutter Hill Ventures, Tencent, Varian Medical Systems, and other financial partners. For more information, please visit www.grail.com.

HEY , its pretty crappy at the moment but it wasn't a surprise if you study the charts , big bounce is expected and day now but after that should have another leg down . that's the time to get in some good names for the next bull market IMO

Hi Change, How are you? Bad days for the crypto..,(without sarcasm) .

good news.

hey ill post here

Headed to Boston today to watch the short doc
Llbo

Llbo

LLBO on its way

LLBO - posting here

llbo

4

3

2

1

MY NEW UPDATE ON LLBO

they just entered into a contract with salesforce, 2 weeks ago,to handle all the documentation for each patient to be downloaded/recorded ,which is very important if the FDA wants to come in during the trials and examine any patient .All the forms that needed to be created for the patients have all been done,next thing that happens in the hospital, it goes to the legal department ,which went back and forth between our legal(CH) team and the hospitals about 2 or 3 weeks ago,then the agreement is signed then goes to the president of the hospital who signed the clinical trials agreement a week ago,that's all done now ,
now we focus on Flextronics to get the patches and recording devices delivered ,estimated production and shipment date of June 15,soon after the trials will be started .(delays happen so to be safe let say + another week or two,jmo)

once the trials are completed and summarized they will file for the 501k(investigational device) ,probably wont happen till October ,and at the same time they will file for the CE mark to sell over seas ,Ce mark takes 90 days to get fda 6-9 months from the date filled .
they will be meeting with FDA in July in Washington bringing them up to speed ,and applying for fast track which we may get lucky and see 4-6 months ,but no guarantee i want stress that just cause they apply for fast track wont mean it will happen , safer to say 6-9 months

in the trials
the process is the woman has a mammogram, then she has our test and then the biopsy ,we know the results of the woman as soon as the information of the biopsy is available, we then know how we compared to the mammogram.
were going to test the first 50 women for 12hrs ,if the correlation is coming up to what we except it should ,then were going to drop our test from 12hrs to 6 hrs ,then test another 50 women and if the correlation is there at 6 hrs ,then we drop it down to 2 hrs.
the other thing thats going to happen is they are going to get publication from peer review journals of the results of the test

this my DD do your own DD
Replies:
$LLBO MY NEW UPDATE ON LLBO (from change-for-a-buck)
$Pistol Pete$ on 6/9/2015 12:41:11 AM
excerpt/ LLBO
mick on 6/9/2015 12:49:27 AM



Report TOS

MY UPDATE
The increase in shares was to settle some debt ,and the only one that they will do, Jim Holmes said no reason to increase shares in Lifeline .
They aren't doing any funding in llbo so will leave it alone "there will be no more issuance of shares!!" "i promise you"(jim holmes)
Cyrcadia raised and still raising money , currently at .50 cents share for the start of trials ,then again later for market entry for outside the United States,which should occur in Q1 - Q2 of 2016 ,and a final raise will be for entering the US market Q2 -Q3 the total raise for all those three events ,estimated is $12million .
right now cyrcadia has 21.5million shares ,llbo owns 8million,
When they raise money we will still have the 8 million shares ,maybe a smaller %but higher value (ill explain)plus royalty
Cyracdia should increase their shares around 15% to the raise money to get threw the trials , at first it seems bad but every time they raise money it will be for a higher price/next stage,the overall value will go up because of what they have achieved .
this isn't the type of dilution that decrease value ,its the opposite,
every time they raise money they will be raising the price because they will be in the later stages in the "game"
.Llbo still owns 8 million shares ,that will never change .50cents x 8million shares =$4million))right now)
the next raise will be at least $1- $2.50 a share when trials are done and applying for FDA/Ce regulatory markets
($1-2.50 x 8 million shares =$8million- $20million major value added, when they complete the trials and apply for both regulatory markets .
estimates for last round of raising cash for market entry outside USA 2.50-$5.00 a share x 8 million $20-40million
when they start sales oversees the estimated value of Cyrcadia shares will be at $5.00 a share .
when they are in both markets overseas and US, estimates are at $9-$11 a share x*8million plus royalty($72-$88million )(and that's probably the first year alone)
They are just finishing all the documentation for preparation for the testing to start first of June2016 .Allot of moving parts ,reason for delays ,so wouldn't be surprised for a week delay
the way the trials are set up ,they should last 4 -5 months months but could be longer or shorter .ill explain
A patient/women has mammogram if it indicates she needs a biopsy and before she does have it "we"ask her if she would take this Cyrcadia test that's strictly voluntary that will help detect cancer at a early stage ,and help women in the future etc.,they then wear the device for 12 hrs and get data.They have to test 173 women that's whats required by the FDA.could be 3 months or ,
could be 4-5 months .IMO i don't see many women saying no to a non invasive test .
500 patches will start being delivered the week of the May 26 ,will have 5 different sizes ,only to be worn for 12hrs not full 24 hrs like last set of test /trials .
trials being managed by Dr Farrar
-this is my D/D ,do your own Due Diligence.-
Replies:
Thank you!!
goldywang on 5/19/2015 10:38:28 AM
Great summary. Thanks
TBaggins on 5/19/2015 10:59:24 AM
Thanks for the update Change.
Ronin_Trader on 5/19/2015 11:30:51 AM
Thanks Change.
ACWprime on 5/19/2015 11:49:43 AM
sounds like a good place to be..but how
frodo66 on 5/19/2015 1:20:09 PM



Report TOS

Upon completion of primary trial (estimated by Dec 2015). We will immtediately prepare and file for FDA and CEMArk regulatory clearance. The 2017 completion mentioned is only for those patients requiring follow up and does not prevent us from the initial filing! The CEMark clearance for sales o/side the U.S. marketing is expected in prox (estimate) 120 days. FDA clearance take longer, which we estimate in the 2nd half of 2016?

llbo

LLBO

LLBO

LLBO

LLBO

https://www.tumblr.com/reblog/125368595355/99O3kPzf

https://mobile.twitter.com/nursebarbdehn/status/625798231813980160

Mobile Devices Driving Unprecedented Growth in Self-Monitoring Technologies Markets, According to BCC Research
June 29, 2015
Additional Reports
Wellesley, Mass., June 29, 2015 – Mobile device users who downloaded at least one health-related application onto their smartphone doubled between 2011 and 2012. BCC Research reveals in its new report that as health applications become more user friendly and cellular technologies expand their reach to increasingly remote populations, this trend will accelerate, helping to driving unprecedented growth in the global health self-monitoring markets.

The global market for selected health self-monitoring technologies reached $1.1 billion and nearly $3.2 billion in 2013 and 2014, respectively. This market is forecast to grow at a compound annual growth rate (CAGR) of 42.9% to reach $18.8 billion in 2019.

The present report focuses specifically on technologies that enable the individual to monitor his or her own health. These technologies include wristbands, smartwatches and other peripherals, mobile self-monitoring software applications, smartphones and other mobile “hub” devices that collect data from peripherals as well as their own onboard sensors.

The current, early generation of self-monitoring tools enables users to monitor and record details of their daily activity, from counting steps or miles walked, and floors climbed, to monitoring calorie consumption, as well daily patterns and hours of sleep. Future developments will expand the range of physiological variables that can be self-monitored and enhance the usefulness of the data thus collected.

“About 21 million individuals globally used their smartphones for self-monitoring their health in 2013. Approximately 17 million (81%) of these individuals lived in the U.S., while the remaining 4 million (19%) lived in other countries,” says BCC research analyst Andrew McWilliams. “The number of U.S. smartphone self-trackers is expected to grow at a CAGR of 27.9% (from 2014 to 2019). The number of smartphone self-trackers in other countries is expected to grow from 6.3 million in 2014 to 60.6 million in 2019, with a CAGR of 57.3%.”
http://www.bccresearch.com/pressroom/hlc/mobile-devices-driving-unprecedented-growth-in-self-monitoring-technologies-markets

21 million people used smartphones for health self-monitoring in 2013
Around 17 million (81%) of these individuals lived in the U.S., while the remaining 4 million (19%) lived in other countries, according to BCC Research.

Posted on June 30, 2015 in BCC Research, Remote Monitoring, Research
21 million people used smartphones for health self-monitoring in 2013
Between 2011 and 2012, the number of mobile users who downloaded at least one health-related app onto their smartphone doubled, and that trend will continue, according to latest findings from BCC Research.

The global market for selected health self-monitoring technologies reached $1.1 billion in 2013, and then $3.2 billion a year later. The market is poised to grow at a CAGR of 42.9% to reach $18.8 billion in 2019.

The health self-monitoring technologies BCC is looking at include wristbands, smartwatches and other peripherals, mobile self-monitoring apps, smartphones and other mobile "hub" devices that collect data from peripherals as well as their own onboard sensors.

Right now, these technologies enable users to record details of their daily activity, from counting steps or miles walked, and floors climbed, to monitoring calorie consumption, as well as daily patterns and hours of sleep. Future technologies will take it from there, expanding the range of physiological variables that can be self-monitored and enhancing the usefulness of the data thus collected.

"About 21 million individuals globally used their smartphones for self-monitoring their health in 2013. Approximately 17 million (81%) of these individuals lived in the U.S., while the remaining 4 million (19%) lived in other countries," says BCC research analyst Andrew McWilliams. "The number of U.S. smartphone self-trackers is expected to grow at a CAGR of 27.9% (from 2014 to 2019). The number of smartphone self-trackers in other countries is expected to grow from 6.3 million in 2014 to 60.6 million in 2019, with a CAGR of 57.3%."
http://mhealthspot.com/2015/06/21-million-people-smartphones-health-selfmonitoring-2013/
Leave a Reply
- See more at: http://mhealthspot.com/2015/06/21-million-people-smartphones-health-selfmonitoring-2013/#sthash.YbfQwTpm.dpuf

https://www.economicvoice.com/the-future-of-wearable-tech-for-doctors-and-patients/

http://www.pm360online.com/will-wearables-change-the-future-of-healthcare/

more exposure for ITBRA

http://www.aboutpharma.com/blog/2015/06/11/wearable-devices-e-digital-health-anatomia-di-un-cambio-di-paradigma/

Great! Flextronics will be there.

Wearable are taking off, and the iTbra will be in the middle of the wearable rush!!

here is the list of company's that will show up in July
http://www.wearable-technologies.com/exhibitors-wt-wearable-technologies-conference-2015-usa/

The image looks good. Things are slowly coming along.

LLBO-WT | Wearable Technologies Conference 2015 USA
https://www.wearable-technologies.com/2015/06/stay-focused-nimble-and-honest/

FLEXTRONICS IS SHOWING UP

This just posted Llbo http://editiondigital.net/publication/?i=260716&p=32#{"page":32,"issue_id":260716}

Page 30